May 2019, the international accredited conference, Invest in ME Research, opened its doors to presenters from around the globe. The conference, held in the United Kingdom and hosted completely by this nonprofit, aimed to increase research collaboration with the full...
Research News
Healthy Volunteers Help Drive Research Forward
Image Credit: National Institute of Health For decades, no one has known what causes myalgic encephalomyelitis (ME, commonly called ME/CFS). As a result, this debilitating disease has been very difficult to diagnose and even harder to treat. Funded by a major grant...
What’s Next for the ME/CFS Clinician Coalition?
On March 15-16, leading ME/CFS clinicians from across the United States gathered in Salt Lake City for the second annual ME/CFS Expert Clinician Summit. The goal of this summit was to grow the collaborative network of disease experts, identify ways to expand their...
BHC Participates in NIH-Sponsored ME/CFS Meeting
The NIH will host 3 days of meetings focusing on ME/CFS research. The meeting on April 3 is titled, “Thinking the Future: A Workshop for Young Early Career ME/CFS Investigators”. This is followed on April 4–5 with a meeting titled, “Accelerating Research on ME/CFS”. ...
Jonas Blomberg: BHC Remembers A Gentle Soul and Bright Scientist
Dr. Bateman shares, “When I first met Jonas, while in Sweden in 2016 to deliver a lecture on the IOM clinical diagnostic criteria for ME/CFS, I sensed immediately that he had a keen scientific mind and was genuinely intrigued by ME/CFS. We had several conversations about the clinical manifestations of ME/CFS…
New Research: Gene Variations in ME/CFS
This is one of the largest ME/CFS epigenetic studies to date and identifies new genetic and epigenetic associations relevant to ME/CFS and useful for the development of new treatments. Samples from a well-defined clinic population of ME/CFS patients were used.
Genetics and Epigenetics in ME/CFS
This is one of the largest ME/CFS epigenetic studies to date and identifies new genetic and epigenetic associations relevant to ME/CFS and useful for the development of new treatments. Samples from a well-defined clinic population of ME/CFS patients were used.
Cutting Edge Technology for ME/CFS Biomarker Discovery
Antibodies are Y-shaped proteins that are produced by B cells of our immune system to specifically recognize and bind antigens. Antigens are molecules that instigate antibody production and can be from an invading pathogen or from our own body. Each antibody...
New Insights into Exercise Intolerance and Medication
The Bateman Horne Center is always excited to share important research on ME/CFS and FM happening around the globe. Today, we focus on David Systrom, a pulmonary and critical care physician who researches all forms of exercise intolerance and heads, by request of the...
New Research on Tentative ME/CFS Irritable Bowel Syndrome Subgroup
Do you have irritable bowel syndrome? If you do, you’re not alone - the presence of irritable bowel syndrome (IBS) alongside ME/CFS may constitute a distinct ME/CFS subgroup. This article reviews and summarizes a new research paper Dr. Bateman and colleagues published...
BHC Strives for Excellence
As asserted in our mission statement, the Bateman Horne Center envisions a world where patients with ME/CFS and Fibromyalgia (FM) are readily diagnosed, effectively treated, and widely met with empathy and understanding. To achieve this vision, the BHC is progressing...
NIH Announces Precision Medicine Initiative
Research tends to neglect ME/CFS and FM - until right now. Precision medicine is the emerging scientific idea that medical treatment can and should be maximally efficient by tailoring medicine and healthcare to individual circumstances. Current research studies,...